Scholarlink

Background <p>Recurrent Non-Tuberculous Mycobacterial Pulmonary Disease (NTM-PD) related to treatment with Secukinumab has not been previously documented.</p> Case presentation <p>Despite adherence to treatment and avoiding hot springs, a plaque psoriasis patient experienced persistent NTM-PD relapses.</p> Conclusions <p>There is potential association between Secukinumab, an IL-17A inhibitor, and NTM disease, echoing anti-TNF biologics’ NTM risk, indicating the urgent need for further research on pathogenic mechanisms and risk factors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Recurrent NTM pulmonary disease despite avoidance of hot spring exposure in a plaque psoriasis patient treated with Secukinumab: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月20日

查看全文
  • Yixiao Wei,
  • Chunlei Wang,
  • Lingtao Chong,
  • Xiaojing Cui

摘要

Background

Recurrent Non-Tuberculous Mycobacterial Pulmonary Disease (NTM-PD) related to treatment with Secukinumab has not been previously documented.

Case presentation

Despite adherence to treatment and avoiding hot springs, a plaque psoriasis patient experienced persistent NTM-PD relapses.

Conclusions

There is potential association between Secukinumab, an IL-17A inhibitor, and NTM disease, echoing anti-TNF biologics’ NTM risk, indicating the urgent need for further research on pathogenic mechanisms and risk factors.